Boy May Force Change in Norway Bio-Ethics Law

Boy May Force Change in Norway Bio-Ethics Law “A campaign to save a six-year-old Norwegian boy with a life-threatening blood disorder looked likely Thursday to force Norway to relax strict biotechnology laws in a stinging defeat for the government. “


Biotech uptick moves into March

Biotech uptick moves into March: “February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, […]


And When ImClone's Drug Doesn't Work…

And When ImClone’s Drug Doesn’t Work… It’s not all roses for Erbitux: “The drug dramatically shrinks colon tumors in some patients. But in others, it has little effect — and no one knows why. “


The perilous path of biotech drugs

The perilous path of biotech drugs “The idea for a revolutionary new drug to treat allergies and asthma came to scientist Tse Wen Chang in a dream … It would take 16 years and cost the Changs and their partners, Genentech and Novartis, hundreds of millions of dollars to develop the drug and win government […]


Pfizer Wins One For Sane Patents

Pfizer Wins One For Sane Patents “What’s in a patent? For the drug industry, everything. And that’s why a court appeal that Pfizer won late Friday [Feb 13] is so important. At issue was whether a researcher must actually discover a drug in order to patent it. “


Hospital ventures into stem-cell reimplantation

Hospital ventures into stem-cell reimplantation “Physicians at Caritas St. Elizabeth’s Medical Center recently launched an adult stem-cell reimplantation study to battle acute cardiac disease. Project managers at the center, which is the teaching hospital for Tufts University School of Medicine, say it is the first such program in the world.”


Do NOT follow this link or you will be banned from the site!